N-of-1 Studies to Improve Symptoms and Individualize Treatment Efficacy in Pediatric Inflammatory Bowel Disease
Despite remarkable advances in treatments for inflammatory bowel disease (IBD), 40% of patients continue to have symptoms that are not relieved and have persistent fatigue and poor quality of life. To improve quality of life, individualized approaches to address symptoms troubling to individual patients are needed.
Fola Odetola, M.D., M.P.H. is an Associate Professor in the Division of Critical Care Medicine. His research interests focus on the optimization of health care delivery to critically ill and injured children through process evaluation, including health technology assessment within the pediatric critical care unit, and outcomes assessment.
Research from the National Poll on Children's Health